News · 26 weeks41-70%
2025-11-022026-04-26
Mix2590d
- Other17(68%)
- SEC Filings5(20%)
- Leadership2(8%)
- Dividends1(4%)
Latest news
25 items- PRPhilips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extractionApril 23, 2026 Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in <0.5% of lead extraction procedures [1] but require immediate intervention Bridge Plus allows for rapid response when every second counts by deploying in under two minutes [2] and stopping up to 90% blood loss [3], helping stabilize patients with 30 minutes of hemostasis [4]Bridge Plus was built upon proven Bridge Occlusion Balloon technology, used in more than 50,000 U.S. procedures [5,*], with evidence showing improved survival when staged in advance [6,**] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a globa
- PRPhilips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planningApril 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Rembra platform of scanning systems, including Rembra CT, Rembra RT and Areta RT. The newly cleared systems are designed to help healthcare providers respond to growing demand for imaging and radiation therapy planning by helping to improve speed, efficiency, and access to high-quality imaging. As imaging volumes and clinical
- PRPhilips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applicationsApril 16, 2026 Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical insight across radiology, cardiology, and oncology Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral CT Verida system, bringing its next-generation, AI-powered spectral CT innovation to the United States. AI-based reconstruction integrated into the imaging chain Verida incorporates Spectral Precise Image, with a third-generation Nano-panel Precise dual-layer detector with intrinsic noi
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- PRFDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repairMarch 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that
- PRPhilips launches IntraSight Plus to simplify coronary interventions and advance precision careMarch 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, has announced the launch of its intuitive interventional guidance platform, IntraSight Plus, which is cleared for clinical use in the USA and Europe. With CE marking and FDA 510(k) c
- PRPhilips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicantMarch 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips' platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips' innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically underserved communities. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it ranked No. 1 among medical technology companies in the
- PRPhilips convenes the Annual General Meeting of Shareholders 2026March 23, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.Proposal to re-appoint Roy Jakobs (Dutch/German, 1974) as President/CEO and Chairman and memb
- PRPhilips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointmentMarch 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips' Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO. The Supervisory Board wil
- PRPhilips Sonicare declares World Oral Health Night, spotlighting what manual brushing leaves behindMarch 20th, Philips Sonicare invites New Yorkers to rethink their nightly clean with an inside look at what happens in your mouth while you sleepCAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) and its Sonicare brand, the #1 Dental Professional recommended sonic toothbrush brand worldwide, is marking World Oral Health Day by declaring it World Oral Health Night drawing attention to a common risk to your oral health many people overlook: assuming manual brushing always removes enough plaque. The science shows why this moment before bed is so i
- PRPhilips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuiteMarch 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows. Philips IntelliSite Pathology Solution on HealthSuite¹, powered by Amazon Web Services (AWS) is a fully cloud-enabled digital pathology solution that helps pathology laboratories adopt and scale digital wo
- PRPhilips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous, actionable understanding of the patient. Health systems are under unprecedented pressure, with rapidly growing data volumes stretching clinical capacity and contributing to care delays. Delays ar
- PRPhilips Sonicare unveils two new electric toothbrush ranges alongside refreshed brand directionSonicare "Feel the Care" invites people to experience the 'Sonicare Feeling' that transforms your daily routine into a ritual of self-care.CAMBRIDGE, Mass., March 5, 2026 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in oral healthcare, today unveiled two new Philips Sonicare electric toothbrush ranges, the integration of Next-Generation Sonicare technology, along with branding, packaging and sustainability updates that all reflect the brand's bold new platform, "Feel the Care." The refreshed brand and product lineup is designed to inspire consumers to elevate their daily oral care routine with advanced brushing technology.
- PRPhilips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environmentsMarch 4, 2026 CE Marked and 510(k) pending, Rembra's advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging and trauma, helping to improve comfort for complex patients and may reduce the need for rescansNext-generation NanoPanel Precise XD detector with AI is built for dose-efficient, high-resolution imaging to support clear visualization and delineation of anatomical structures Amsterdam,
- PRSHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatmentsMarch 3, 2026 With a total budget of EUR 21.5 million, the four-year SHERPA research project is coordinated by Philips and co-funded by the EU Innovative Health Initiative (IHI) and industry partnersThe project focuses on developing automated workflows for minimally invasive neurovascular and tumor treatments – clinical procedures where staffing levels and specialized expertise are in short supplyThe clinical studies are being conducted at University Medical Center Utrecht, St Antonius Hospital, University Medical Center Hamburg-Eppendorf, Hôpital Bicêtre AP-HP, and Hospital de la Santa Creu i Sant PauOn March 4 (16:30 - 17:30 CET), SHERPA will be featured at the European Congress of Radiol
- SECSEC Form 20-F filed by Koninklijke Philips N.V. NY Registry Shares20-F - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- PRPhilips publishes its Annual Report 2025February 19, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today published its Annual Report 2025. Philips' Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to file the report on Form 20-F with the U.S. Securities and Exchange Commission later today (www.sec.gov). The Annual Report 2025 (in
- PRPhilips introduces InkSpace Imaging's Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfortFebruary 12, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality imaging for clinicians. Young patients often find MRI exams challenging, and the Snuggle™ coil was created to make the experience more comfortable and less intimidating. Its light, blanket-like design and soft, flexible structure gently wrap around th
- PRSEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatmentsFebruary 11, 2026 Co-funded by the EU's Innovative Health Initiative (IHI), the research consortium is coordinated by Philips, together with Erasmus MC as academic lead, and will combine advanced medical imaging and minimally invasive techniques to transform treatment of bleeding and tumors in the brainFive-year research program with total budget of EUR 38.4 million includes eight clinical studies to validate technical solutions for minimally invasive neurosurgery Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that the SEISMIC research consortium, coordinated by Philips, together with Erasmus MC as academic lead, has
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- SECSEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
- PRPhilips proposes to re-appoint CEO Roy JakobsFebruary 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board's recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. "Roy Jakobs has demonstrated clear leadership, strong execution
- PRPreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive breakthroughs in precision cancer treatmentFebruary 3, 2026 Co-funded by the EU's Innovative Health Initiative (IHI), the Philips-coordinated research consortium will combine advanced medical imaging, robotic guidance technologies, and AI to standardize and enhance the precision of minimally invasive cancer treatmentsFive-year research program with total budget of EUR 23.9 million includes five clinical studies to validate the technical solutions, with the aim of setting a new benchmark for precision, safety, and efficiency in minimally invasive cancer care Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that the PreciseOnco consortium, coordinated by Philips,
PHG FAQ
7 questionsWhat does Koninklijke Philips N.V. NY Registry Shares do?
Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging...Where does PHG stock trade?
Koninklijke Philips N.V. NY Registry Shares (PHG) is listed on NYSE.What sector and industry is PHG in?
Koninklijke Philips N.V. NY Registry Shares operates in the Health Care sector, Medical Electronics industry.Does PHG pay a dividend?
Yes. PHG's next ex-dividend date is 2026-05-13 with a declared cash dividend of $1.01 per share, payable 2026-06-03.What are analysts saying about PHG?
Koninklijke Philips N.V. NY Registry Shares has had 8 recent analyst actions on file. The most recent action was from RBC Capital Mkts: Sector Perform on 2025-12-17.What companies are similar to PHG?
Notable peers in the same industry include GEHC (GE HealthCare Technologies Inc.), HOLX (Hologic Inc.), BFLY (Butterfly Network Inc.), NNOX (NANO-X IMAGING LTD), CHEK (Check-Cap Ltd.). Compare PHG side-by-side with any of them on Quantisnow.How can I track PHG on Quantisnow?
Quantisnow aggregates Koninklijke Philips N.V. NY Registry Shares's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PHG to receive live email and push alerts on every new disclosure.